Side effects, images, and drug details for Idhifa - Inside Rx
Back to Search Results

Idhifa

enasidenib
Enasidenib targets a specific gene mutation called IDH2, which can affect your bone marrow. IDH2 mutation prevents young blood cells from developing into healthy adult blood cells, which can result in symptoms of acute myeloid leukemia. Enasidenib is used to treat acute myeloid leukemia (AML) in adults with an IDH2 mutation. This medicine is used when AML has come back or has not improved with prior treatment. Enasidenib may also be used for purposes not listed in this medication guide.
CHEMICAL NAME
enasidenib
DRUG TYPE
miscellaneous antineoplastics

Frequently Asked Questions

Enasidenib can cause a condition called differentiation syndrome, which affects blood cells and can be fatal if not treated. This condition may occur within 10 days to 5 months after you start taking enasidenib.

Seek medical help right away if you have symptoms of differentiation syndrome: fever, cough, trouble breathing, bone pain, rapid weight gain, or swelling in your arms, legs, underarms, groin, or neck.

Similar Drugs

Brand Name Examples Supplied As Strength
Idhifa tablet 100 mg50 mg

Save up to 80% on brand & generic medications.